Details for New Drug Application (NDA): 020372

✉ Email this page to a colleague

NDA 020372 describes MYOVIEW 30ML, which is a drug marketed by Medi-physics and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the MYOVIEW 30ML profile page.

The generic ingredient in MYOVIEW 30ML is technetium tc-99m tetrofosmin kit. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the technetium tc-99m tetrofosmin kit profile page.

Summary for 020372

Tradename:	MYOVIEW 30ML
Applicant:	Medi-physics
Ingredient:	technetium tc-99m tetrofosmin kit
Patents:	1

DrugPatentWatch^® Estimated Loss of Exclusivity (LOE) Date for 020372

Generic Entry Date for 020372^: ⤷ Sign Up* Constraining patent/regulatory exclusivity: ⤷ Sign Up Dosage: INJECTABLE;INJECTION

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Suppliers and Packaging for NDA: 020372

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
MYOVIEW	technetium tc-99m tetrofosmin kit	INJECTABLE;INJECTION	020372	NDA	Medi-Physics Inc. dba GE Healthcare	17156-024	17156-024-05	5 VIAL in 1 KIT (17156-024-05) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
MYOVIEW	technetium tc-99m tetrofosmin kit	INJECTABLE;INJECTION	020372	NDA	Medi-Physics Inc. dba GE Healthcare	17156-026	17156-026-30	5 VIAL in 1 KIT (17156-026-30) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	N/A
Approval Date:	Feb 9, 1996	TE:		RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	N/A
Approval Date:	Jul 7, 2005	TE:		RLD:	Yes
Patent:	⤷ Sign Up	Patent Expiration:	Mar 10, 2030	Product Flag?	Y	Substance Flag?		Delist Request?

Expired US Patents for NDA 020372

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Medi-physics	MYOVIEW	technetium tc-99m tetrofosmin kit	INJECTABLE;INJECTION	020372-001	Feb 9, 1996	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.